Ju Sang Kim Selected Research

Ju Sang Kim Research Topics

Disease

8	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2021 - 01/2015
6	Tuberculosis (Tuberculoses) 01/2022 - 06/2012
5	Chronic Obstructive Pulmonary Disease (COPD) 09/2020 - 01/2017
4	Lung Neoplasms (Lung Cancer) 01/2021 - 05/2020
4	Asthma (Bronchial Asthma) 09/2013 - 08/2009
3	Neoplasms (Cancer) 01/2022 - 09/2020
3	Pleural Effusion (Pleural Effusions) 01/2022 - 09/2012
3	Inflammation (Inflammations) 05/2021 - 08/2009
3	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 10/2015 - 04/2011
3	Respiratory Hypersensitivity 09/2013 - 08/2009
2	Pulmonary Tuberculosis 01/2022 - 09/2019
2	Latent Tuberculosis 09/2021 - 10/2019
2	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 08/2020 - 01/2019
2	Pneumonia (Pneumonitis) 05/2020 - 07/2012
2	Airway Remodeling 07/2012 - 05/2010
1	COVID-19 05/2022
1	Autoimmune Diseases (Autoimmune Disease) 01/2022
1	Hyperkalemia 01/2022
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 08/2021
1	Disease Progression 05/2021
1	Lung Diseases (Lung Disease) 08/2020
1	Carcinoma (Carcinomatosis) 05/2020
1	Neutropenia 05/2020
1	Anemia 05/2020
1	Pulmonary Edema 05/2020
1	Dyspnea (Shortness of Breath) 01/2017
1	Hypertension (High Blood Pressure) 10/2015
1	Hypokalemia 10/2015
1	Cushing Syndrome 10/2015
1	Paraneoplastic Endocrine Syndromes 10/2015
1	Alkalosis 10/2015
1	Small Cell Carcinoma 10/2015
1	Fistula 01/2015
1	Sarcoma (Soft Tissue Sarcoma) 01/2015
1	Pleural Tuberculosis 09/2012
1	Infections 09/2012
1	Hypertrophy 07/2012
1	Pathologic Constriction (Stenosis) 06/2012
1	Airway Obstruction (Choking) 06/2012
1	Tracheal Stenosis 06/2012
1	Wounds and Injuries (Trauma) 09/2010

Drug/Important Bio-Agent (IBA)

4	CytokinesIBA 09/2013 - 08/2009
3	Isoniazid (Ftivazide)FDA LinkGeneric 11/2021 - 09/2019
3	Immune Checkpoint InhibitorsIBA 08/2021 - 01/2021
3	ErbB Receptors (EGF Receptor)IBA 07/2020 - 01/2015
2	Linezolid (Zyvox)FDA Link 01/2022 - 01/2019
2	AcidsIBA 01/2022 - 08/2020
2	PlatinumIBA 11/2021 - 01/2021
2	Interferon-gamma (Interferon, gamma)IBA 09/2021 - 09/2012
2	Pharmaceutical PreparationsIBA 05/2020 - 07/2012
2	belotecanIBA 10/2013 - 04/2011
2	CamptothecinIBA 10/2013 - 04/2011
2	OvalbuminIBA 07/2012 - 05/2010
2	CollagenIBA 07/2012 - 05/2010
1	SARS-CoV-2 spike proteinIBA 05/2022
1	Neutralizing AntibodiesIBA 05/2022
1	Nucleic AcidsIBA 05/2022
1	delpazolidIBA 01/2022
1	Adenosine DeaminaseIBA 01/2022
1	ParaffinIBA 12/2020
1	Carbon MonoxideIBA 09/2020
1	Biological ProductsIBA 09/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	rifapentine (Priftin)FDA Link 10/2019
1	Rifampin (Rifampicin)FDA LinkGeneric 09/2019
1	Ethambutol (Myambutol)FDA LinkGeneric 09/2019
1	OPC-67683IBA 01/2019
1	Pyrazinamide FDA LinkGeneric 01/2019
1	FluoroquinolonesIBA 01/2019
1	Levofloxacin (Levaquin)FDA Link 01/2019
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2019
1	Bronchodilator Agents (Bronchodilators)IBA 01/2017
1	RoflumilastIBA 01/2017
1	Type 4 Cyclic Nucleotide PhosphodiesterasesIBA 01/2017
1	Ketoconazole (Nizoral)FDA LinkGeneric 10/2015
1	Spironolactone (Aldactone)FDA LinkGeneric 10/2015
1	Adrenocorticotropic Hormone (ACTH)FDA Link 10/2015
1	Anaplastic Lymphoma KinaseIBA 01/2015
1	Interleukin-5 (Interleukin 5)IBA 09/2013
1	Nerve Growth Factor (NGF)IBA 09/2013
1	Tissue Inhibitor of Metalloproteinase-1IBA 09/2013
1	Interleukin-13IBA 09/2013
1	InterleukinsIBA 09/2013
1	GoldIBA 09/2012
1	AntigensIBA 09/2012
1	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA 07/2012
1	Acetylcholine (Acetylcholine Chloride)FDA Link 07/2012
1	Cholinergic Antagonists (Anticholinergics)IBA 07/2012
1	Tiotropium Bromide (Spiriva)FDA Link 07/2012
1	Phosphates (Orthophosphate)IBA 07/2012
1	SiliconesIBA 06/2012
1	CausticsIBA 09/2010

Therapy/Procedure

4	Drug Therapy (Chemotherapy) 11/2021 - 01/2018
4	Therapeutics 08/2021 - 08/2009
3	Radiotherapy 08/2021 - 05/2020
2	Immunotherapy 11/2021 - 08/2021
1	Bronchoscopes 12/2020
1	Pneumonectomy (Lung Volume Reduction) 01/2015
1	Electrocoagulation (Electrocautery) 06/2012
1	Stents 06/2012